ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Clinical trials for ADVANCED CCNE1-AMPLIFIED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CCNE1-AMPLIFIED SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED CCNE1-AMPLIFIED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced breast cancer patients in early drug trial
Disease control Recruiting nowThis early-stage study is testing a new drug called GVV858, both by itself and combined with standard hormone therapies, for people with advanced breast cancer and other solid tumors. The main goals are to find a safe dose and see how well the body handles the drug. Researchers w…
Matched conditions: ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Novartis tests new weapon against tough breast cancers
Disease control Recruiting nowThis study is testing a new drug called ECI830 for people with advanced breast cancer that has stopped responding to standard hormone therapies. Researchers want to see if ECI830 is safe and effective when given alone or combined with two existing cancer drugs. The trial will enr…
Matched conditions: ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC